VEGFA and diabetic macular edema: Post hoc analyses from multicentered clinical trials using anti-VEGF therapy to treat diabetic macular edema have further demonstrated a significant reduction in the progression to PDR in some—but not all—patients with NPDR receiving monthly anti-VEGF therapy (7–9).